Homburger has advised Windward Bio Group AG. Wilson Sonsini Goodrich & Rosati and BGParnter have advised OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, and Omega Funds....
Windward Bio Group Secures USD 165 Million in Series B Financing Round
Windward Bio and Qyuns Therapeutics Enter USD 700 Million Licensing Agreement for Immunology Therapy
Homburger has advised Windward Bio. Windward Bio Group AG, through its affiliate LE2025 Therapeutics AG, has entered into a licensing agreement with Qyuns Therapeutics Co., Ltd....
Windward Bio Group AG’s $200 Million Series A Financing Round
Homburger AG advised Windward Bio on its set-up and financing, and Ropes & Gray advised RTW Investments. Windward Bio Group AG, a Swiss-based private, clinical-stage, drug...
Windward’s Initial Public Offering
Yigal Arnon & Co. represented Windward in the deal. CMS has advised Canaccord Genuity Limited. Windward executed a LSEG initial public offering. Windward is an Israeli company that...